CBD Vegan Capsules For Sleep: Medically Reviewed

Perfect just before bed, introducing vegan Night Capsules put your mind and body at ease, making sleep not only easier but longer and more restful. Blending highly-effective cannabinoids like broad spectrum CBD, CBN, sleep-enhancing botanicals, and a specialized mix of calming terpenes for a solid night’s rest.

“Combining CBD with valerian root and GABA, which have all been shown to help promote more restful sleep, is a great idea for a sleep product. The brightly colored purple box helps distinguish this product for nighttime use. The use of CBN in addition to the CBD to help promote relaxation is very effective, as well. I found that this product helps me fall asleep faster and sleep more soundly. The effects were felt after around 30 minutes, and I did not notice any grogginess the next morning. I even had my mother-in-law try it when she came to stay with us and she said she slept better away from home using this product than she ever had. This is even something that I could see using occasionally to help induce sleep/relaxation, especially if I was feeling stressed.

This product could be your answer to a better night’s sleep!”

CLICK HERE TO ORDER

Experience The Nirvana CBD Difference

Free Shipping on All Orders Over $50

Enjoy A Broad Spectrum Of CBD Products.

Featuring a wide selection of ultra-premium, lab-tested CBD products–including CBD oils, topicals, gummies, and softgels–Nirvana CBD is the leader in high-quality CBD!


About Nirvana CBD
Nirvana CBD was founded in 2017 with an emphasis on honest core values. Yet, Nirvana CBD is more than just a product and far more than just a company, they are a team of talented individuals and a family who deeply care for the well-being of others. They aim to provide natural relaxation for consumers.



Get new content delivered directly to your inbox.

Nevada Leads The Way For Veterinarians To Treat Pets With CBD

Starting this October, veterinarians licensed in Nevada can recommend and administer hemp and cannabidiol products containing not more than 0.3% tetrahydrocannabinol without fear of sanction from the state licensing board.

Earlier this year, Gov. Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. The Nevada Board of Veterinary Medical Examiners helped write AB 101, which the Nevada VMA supported, according to NVMA Executive Director Michelle Wagner.

The bill’s sponsor, State Assemblyman Steve Yeager, introduced the measure in February because Nevada law was unclear about whether veterinarians were permitted to administer CBD products or discuss them with pet owners.

“Because of the ambiguity in our law, I learned that many veterinarians chose not to talk about CBD with pet owners for fear of being disciplined,” Yeager said. “This left pet owners in a tough spot because CBD products are generally unregulated, and it would be difficult for a pet owner to know exactly what to purchase or administer without the professional advice of a veterinarian.”

Nevada voters approved medical marijuana for people by ballot initiative in 2000. Cannabis became legal for recreational use in the state on Jan. 1, 2017, following a 2016 ballot measure.

AB 101 encountered no opposition and passed the state Assembly and Senate without a single no vote, Yeager explained.

“I certainly hope that other states follow Nevada’s lead and provide reassurances to licensed veterinarians that they can administer CBD or talk about it with patients without fear of facing disciplinary proceedings,” he said. “The bill itself is fairly simple and, thus, is a good model for other states.”

Although products containing 0.3% or less THC are exempted from the federal Controlled Substances Act, the products do fall under the Federal Food, Drug, and Cosmetic Act if they are used therapeutically or included in animal food. The Food and Drug Administration considers the therapeutic use of these products to be the use of unapproved drugs.

A Simple Question

But do medical cannabinoids actually help animal patients?

It’s a deceptively simple question at the heart of an animal health concern complicated by a tangle of federal and state regulations, research challenges, and species-specific pharmacokinetics.

Dr. Dawn Boothe is a professor of veterinary physiology and pharmacology at Auburn University studying cannabis’s potential as a veterinary treatment. She sought to make sense of the issues during her presentation “Medical Cannabinoids Revisited” at AVMA Virtual Convention 2021 on Aug. 1.

The cannabis sativa plant contains more than 90 unique compounds, or cannabinoids, including CBD and THC, as well as almost 500 other terpenoids and phenylpropanoids. For several millennia, humans have used cannabinoids for pain, epilepsy, gastrointestinal disorders, and even infections.

Dr. Boothe said research interest in the therapeutic use of cannabis in the United States essentially came to a “screeching halt” in 1971 with the federal Controlled Substances Act, which listed cannabis as a Schedule 1 drug, meaning the federal government regarded cannabis as having no therapeutic properties and a high potential for abuse.

“That’s changed in the last couple of decades as, increasingly, states are paying attention to medical cannabinoids,” Dr. Boothe said. “But I do shudder to think sometimes about how much we would have learned if we had taken a different path in our reaction to cannabis.”

The federal government’s position on cannabis has somewhat softened in recent years, most notably with the 2018 Farm Bill’s removal of industrial hemp containing 0.3% or less of THC from the Controlled Substances Act. That said, the use, sale, and possession of cannabis over 0.3% THC, despite laws in many states permitting it under various circumstances, is illegal under federal law.

Making Sense of It All

The restrictions on veterinarians haven’t diminished interest among pet owners, who have available to them a veritable pharmacopeia of CBD products claiming to treat any number of animal ailments and behavioral problems.

None of the products are approved by the FDA, which, as Dr. Boothe explained, raises concerns about variability in cannabinoid concentrations, mislabeling, and contamination with harmful additives, such as fentanyl or synthetic cannabinoids.

“If you’re looking for a product that has a certificate of analysis that you can have faith in—as I would—go to the USDA (U.S. Department of Agriculture) website and look at the laboratories that the DEA (Drug Enforcement Administration) has approved as being appropriate for analysis of hemp crops,” Dr. Boothe said. “That at least can increase the level of validity for that product.”

Then there are questions about what constitutes a therapeutic dose of cannabinoid in a particular species as well as which formulations actually deliver that dose to the animal patient. There’s evidence that, in dogs, the route of CBD administration, such as in a soft capsule containing oil, may increase the oral bioavailability, according to Dr. Boothe.

“Hemp seed oil, sesame seed oil, and medium-chain triglycerides are the most common oils that are being used,” she said. “We need to see data demonstrating the differences in oral bioavailability among these different compounds.”

Cats are more challenging. “We’re going to have to have some good pharmacokinetic studies providing us information about dosing and cats,” Dr. Boothe said. “We have demonstrated that in cats there is variability in absorption, but, as in dogs, feeding will enhance that absorption.”

Dogs appear to tolerate CBD far better than THC, which was shown to cause ataxia when administered intravenously in smaller, less-concentrated doses than CBD. Dogs were also found to build a tolerance to cannabinoids over time.

Continue Reading On American Veterinary Medical Association

Recent Cannabis Articles

Get new content delivered directly to your inbox.

Cryptocurrencies & Cannabis Are A Match Made In Heaven

Cryptocurrency is the solution to the cannabis industry’s banking problem that stems from the DEA’s outdated Schedule I status of cannabis as a controlled substance instead of the natural healing plant that it is. In comparison, investors of cryptocurrency and consumers of cannabis products are individuals of society who understand the power of innovation and elevation.

Article By K. Crystal Carter

K. Crystal Carter is originally from Oakland, California, where she was employed in banking for 7.5 years and a cannabis grow director and cannabis advocate at local City Hall meetings for 6 years. She currently resides in Las Vegas as one of the lead Earthy Realist team members.

Recent Articles From EarthyRealist.com

Get new content delivered directly to your inbox.

RastaCake Decentralized Exchange Is Leading The CryptoCannabis Revolution

RastaCake has been developed to be the #1 AMM Decentralized Exchange for Tokenized Cannabis stocks, and a bridge between the traditional stock market and crypto market, making it easier to invest in cannabis stocks and assets placed in different countries at the same time from anywhere in the world.

What Are Tokenized Stocks?

Tokenized stocks are tokenized derivatives that represent traditional securities, particularly shares in publicly listed companies traded on regulated exchanges such as Scotts Miracle-Gro, Curaleaf, Aurora, Apple, Tesla and others.

The key benefits of tokenized stocks include fractional ownership of traditional securities, 24/7 access to markets, and greater liquidity to name a few. These digital assets are backed 1:1 by traditional stocks, entitling holders to the same economic benefits of owning the underlying stock.

What is AMM?

AMMs systems took off after they were first implemented by Shearson Lehman Brothers and ATD in the early 1990s.

In crypto, AMM is being used for the most important existing decentralized exchanges like Uniswap and PancakeSwap and it allows digital assets to be traded in a permissionless and automatic way, by using liquidity pools rather than a traditional market of buyers and sellers. Prices are determined by a constant mathematical formula.

Liquidity pools can be optimized for different purposes and are proving to be an important instrument in the DeFi ecosystem

RastaCake it’s a AMM Decentralized Exchange community owned, which means that all liquidity pools are managed and owned by the community sharing the profit from all transactions on the exchange.

Earn Passive Income

RastaCake is a community owned and driven project. All Profit-sharing from all liquidity pools and transactions fees on the exchange are distributed to $RCAKE holders, everyday at 4:20 PM in form of $ETH or $RKACE automatically deposited to your wallet . The tech behind this project will be managing the pools and farms so users can sit back, relax, and receive their profits automatically deposited in their Wallet.

A Secure Platform To Trade And Launch 4:20 Friendly Tokens

Their goal is to create a platform where any cannabis initiative can receive funds with RastaCake. This can include startup projects or already established cannabis businesses. They will be able to issue tokens backed in real stocks or assets.

$RCAKE Token Details

$RCAKE is the governance token of the RastaCake project and it’s mandatory to participate on voting and funding. When a new token is offered on market, having $RCAKE will be necessary in order to participate and the $RCAKE used will be burned to reduce the token supply.

Join The CryptoCannabis Revolution Today!

Article Sourced By EarthyRealist.com Via RastaCake


Recent Cannabis Articles

Get new content delivered directly to your inbox.